NCT04950075Phase 2Active not recruiting

Study of INBRX-109 in Conventional Chondrosarcoma

Study sponsor: Inhibrx Biosciences, Inc · INBX

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2025-09-30Actual

Enrollment · participants206Actual

Source updated2026-07-14Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-01-09 · 5 fields changed

Participant count type changed

− Before

~~Estimated~~

+ After

Actual

Enrollment · participant count changed

− Before

~~201 participants (planned)~~

+ After

206 participants (actual)

Completion date type changed

− Before

~~Estimated~~

+ After

Actual

Primary completion date changed

− Before

~~Sep 2025~~

+ After

30 Sep 2025

Recruitment status changed

− Before

~~Recruiting~~

+ After

Active not recruiting

Check registry source